ClinicalTrials.gg
Not yet recruitingNCT07943624EFT in ANUpdated Nov 17, 2026

Is Restrictive Eating Behavior in Anorexia Nervosa Short-sighted? An Experimental Investigation

An interventional study of Episodic Future Thinking and Standardized Episodic Thinking in Anorexia Nervosa, sponsored by New York State Psychiatric Institute. Not yet recruiting at 1 site in United States. Open to female participants aged 18 Years to 34 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by New York State Psychiatric Institute · Not applicable, Interventional, and Basic science

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 34 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 24 studies in Anorexia Nervosa by New York State Psychiatric Institute — 5 open to participants now, 5 under way, none of them phase 3. Anorexia Nervosa · New York State Psychiatric Institute.

Planned enrollment
5th of 15
64 · median 41
Started
2026
with 1 other
No phase
10 of 24
4 open now
Registered
24th of 24
by date

Among the 24 studies in Anorexia Nervosa by New York State Psychiatric Institute, this one is the 5th largest by planned enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2026, is one of 10 with no phase, and was the 24th registered.

Anorexia Nervosa

471 studies on the registry are indexed under Anorexia Nervosa; 128 are open to participants now.

Browse Anorexia Nervosa studies →

Open to participants now

5 of the 24 studies in Anorexia Nervosa by New York State Psychiatric Institute are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 82 Anorexia Nervosa studies recruiting now, 18 (22%) set no upper age limit and 60 (73%) stop at 75 or younger; 48 take children under 18; 26 take healthy volunteers.

This study: 18 Years to 34 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Anorexia Nervosa by New York State Psychiatric Institute, or all of them as a file.
02

Study summary

The investigators will examine the behavioral effects of an experimental Episodic Future Thinking manipulation on food choice, as well as the ability to engage the neural circuits supporting Episodic Future Thinking during food choice, among individuals with anorexia nervosa (AN) and healthy controls.

03

Conditions studied

  • Anorexia Nervosa

Browse trials for

Keywords

  • anorexia nervosa
  • mechanism-based research
  • decision making
04

Who can participate

Ages eligible
18 Years to 34 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Individuals with Anorexia Nervosa:

  1. diagnosis of AN
  2. Right-handed
  3. Hospitalized as an inpatient at New York State Psychiatric Institute
  4. Able to provide

Healthy controls:

  1. Right-handed
  2. ≥ 18.5 and ≤ 25 kg/m2
  3. No history of eating disorder or other psychiatric illness
  4. Not currently dieting
  5. Able to provide informed consent

Exclusion criteria

Exclusion Criteria

Individuals with Anorexia Nervosa:

  1. Current or lifetime history of schizophrenia, bipolar disorder, or other psychotic-spectrum disorder
  2. High risk of suicide
  3. Food allergy that would interfere with study participation
  4. Daily psychotropic medications within 1 month of the study
  5. Major neurological problem that might affect interpretation of findings
  6. Indwelling metallic object (e.g. braces, non-removable metal jewelry, medicinal patch or recent metallic ink tattoo)
  7. Significant claustrophobia
  8. Pregnancy

Healthy controls:

  1. Any current or lifetime eating disorder
  2. Any current psychiatric disorder
  3. Current psychotropic medication
  4. Food allergy that would interfere with study participation
  5. Major medical or neurological problem that might affect interpretation of findings
  6. Indwelling metallic object (e.g. braces, non-removable metal jewelry, medicinal patch or recent metallic ink tattoo)
  7. Significant claustrophobia
  8. Pregnancy
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Episodic Future Thinking then Standardized Episodic Thinking

    This arm involves two experimental manipulations. Participants will complete a task with the episodic future thinking manipulation; after they will complete the same task with the standardized future thinking manipulation.

    Behavioral: Episodic Future Thinking · Behavioral: Standardized Episodic Thinking

  • Experimental
    Standardized Episodic Thinking

    This arm involves two experimental manipulations. Participants will complete a task with the standardized future thinking; after they will complete the same task with the episodic future thinking manipulation manipulation.

    Behavioral: Episodic Future Thinking · Behavioral: Standardized Episodic Thinking

Interventions

  • BehavioralEpisodic Future Thinking

    Participants will be presented with individualized cues to prompt thinking about future scenarios.

  • BehavioralStandardized Episodic Thinking

    Participants will be presented with individualized cues to prompt thinking about recent (standardized) study-related events.

06

What researchers measure

Primary outcomes

  1. High-fat preference

    Participants complete a computerized food decision making task in which they indicate their preference to eat different food items.

    Time frame: Day 1

  2. Reward discount rate

    On a computer task participant selects between smaller monetary rewards available sooner and larger delayed monetary rewards, allowing the discounting of delayed rewards to be calculated.

    Time frame: Day 1

  3. Functional connectivity between ventromedial prefrontal cortex and hippocampus

    Brain activation during study tasks will be assessed with functional magnetic resonance imaging, and functional connectivity between ventromedial prefrontal cortex and hippocampus will be estimated.

    Time frame: Day 1

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — This study will offer participants the opportunity to share data with the National Data Archive. This is not a requirement for participation.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Apr 2028, 17 months later.

Of 150 non-industry interventional studies with no phase under Anorexia Nervosa, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 63. This study's planned 17 months is below that.

Counting every sponsor, half of 150 studies reached it within 43 months; a quarter within 24 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2026
First posted
Nov 17, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
Apr 15, 2028
CompletionEst.
Apr 15, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943624
Responsible party
Caitlin Lloyd (Assistant Professor of Psychiatry at the Columbia University Irving Medical Center, New York State Psychiatric Institute) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Apr 15, 2028 (estimated)
Completion
Apr 15, 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Caitlin Lloyd, PhD
Contact
caitlin.lloyd@nyspi.columbia.edu
646-774-8201

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion